Filter
453
Text search:
registered
pharmaceutical
product
Featured
Recommendations
37
New Publications
134
Language
Document type
No document type
264
Studies & Reports
69
Guidelines
65
Manuals
26
Strategic & Response Plan
13
Training Material
7
Fact sheets
5
Situation Updates
3
Resource Platforms
1
Countries / Regions
Kenya
24
Ethiopia
21
South Africa
19
Nigeria
16
Uganda
16
India
16
Tanzania
15
Liberia
14
Malawi
13
Zimbabwe
12
Sierra Leone
11
Ghana
11
Rwanda
11
Namibia
9
Zambia
8
Western and Central Europe
8
Global
8
Bangladesh
7
Eswatini/ Swaziland
7
Nepal
6
Botswana
6
Philippines
5
Lesotho
5
Cambodia
4
Indonesia
4
Ukraine
4
Myanmar / Burma
4
Senegal
3
Haiti
3
Syria
3
Eastern Europe
3
Albania
3
Sudan
2
Benin
2
North Macedonia
2
Latin America and the Carribbean
2
United Kingdom
2
Burkina Faso
1
Congo, Democratic Republic of
1
Cameroon
1
Pakistan
1
South Sudan
1
Jordan
1
Thailand
1
China
1
Ireland
1
Mozambique
1
Central African Republic
1
Libya
1
Angola
1
South–East Asia Region
1
Asia
1
Africa
1
Venezuela
1
Russia
1
Bulgaria
1
Moldova
1
Iran
1
Australia
1
North America
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
258
Clinical Guidelines
21
Pharmacy & Technologies
19
Key Resources
18
Public Health
10
Capacity Building
5
Women & Child Health
5
Toolboxes
Pharmacy
64
AMR
42
TB
24
HIV
20
COVID-19
15
Mental Health
14
NTDs
10
Conflict
7
Caregiver
6
Global Health Education
5
Disability
3
Rapid Response
3
Planetary Health
3
Malaria
3
Specific Hazards
2
Health Financing Toolbox
2
Ebola & Marburg
1
Cholera
1
Polio
1
Refugee
1
NCDs
1
2.0 Rapid Response
1
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide
...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato
...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improv
...
This resource offers practical guidance in managing the supply chain, with emphasis on health comodities. The handbook is particularly useful for program managers who design, manage, and assess logistics system for health program. The document includes detailed information about the design and imple
...
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and
...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go
...
The Ethiopian Hospital Services Transformation Guidelines (EHSTG) build on and expand the Ethiopian Hospital Reform Implementation Guidelines (EHRIG) and are consistent with the Health Sector Transformation Plan (HSTP). The EHSTG, which is consistent with the national focu
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
First edition, November 1997 | Revised July 2002
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
29 Dec 2021. Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
